| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067223 Prophylaxis or prevention of gastrointerstinal disorders by administering Escherichia |
| 04/08/2004 | US20040067220 Blockade of T cell migration into epithelial GVHD target tissues as an approach to achieving anti-tumor effects against lymphohematopoietic malignancies without GVHD |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | DE10158680B4 Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen A method for ex vivo expansion and differentiation of multipotent stem cells |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2500179A1 Cells on a support matrix for tissue repair |
| 04/08/2004 | CA2499689A1 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | CA2496761A1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | CA2484716A1 Immune t-cell stimulation |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405906A1 Schwann cells originating in myeloid interstitial cells |
| 04/07/2004 | EP1405641A2 Pharmaceutical and/or nutraceutical composition comprising a combination of probiotic non sporogenic microorganisms and spores of Bacillus subtilis and/or Bacillus clausii |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404845A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404815A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 04/07/2004 | EP1404812A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404702A2 Human secreted proteins |
| 04/07/2004 | EP1404379A2 Viral inactivation process using antioxidant |
| 04/07/2004 | EP1404363A2 Adjuvant composition for mucosal and injection delivered vaccines |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1286708B1 Method for producing a bio-artificial transplant |
| 04/07/2004 | EP1238060B1 Method for production of a skin graft and the graft produced thereby |
| 04/07/2004 | EP1234031A4 B7-h1, a novel immunoregulatory molecule |
| 04/07/2004 | EP1198236A4 Bone graft substitute composition |
| 04/07/2004 | EP1164863A4 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
| 04/07/2004 | EP1151004B1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 04/07/2004 | EP1137424B1 Preparation which contains oligosaccharides and probiotics |
| 04/07/2004 | EP1123384B1 Use of compositions depleted of dendritic cells for improving allogeneic hematopoietic cell transplantation |
| 04/07/2004 | EP0559884B2 Viral recombinant vectors for expression in muscle cells |
| 04/07/2004 | CN1487967A A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 04/07/2004 | CN1487843A A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 04/07/2004 | CN1487841A Lentiviral vector-mediated gene transfer and uses thereof |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487798A Combination of probiotics |
| 04/07/2004 | CN1486745A Stem cell prepn for treating tissue ischemia disease and its prepn process |
| 04/07/2004 | CN1486724A Chinese medicine for treating diabetes |
| 04/07/2004 | CN1486719A Chinese medicine for invigorating liver, kidney and spleen, nourishing blood, tranquilizing mind relaxing bowels and the prepn process of the Chinese medicine prepn |
| 04/07/2004 | CN1486717A Chinese medicine for invigorating vital energy and benefiting kidney and the prepn process of the granule |
| 04/07/2004 | CN1486704A Health care medicine for raising immunological function |
| 04/07/2004 | CN1486703A Freeze dried woodfrog oil capsule and its prepn |
| 04/07/2004 | CN1486702A Injection for eliminating wrinkles and scar and its prepn |
| 04/07/2004 | CN1486633A Serial pearl compositions and their making process and application |
| 04/07/2004 | CN1144873C Clostridium butyricum and its use |
| 04/07/2004 | CN1144814C Compound poultry lymphatic factor and producing process thereof |
| 04/07/2004 | CN1144597C Method for preparing genetic antibiotic peptide medicine for animals from transgenic antibiotic peptide muscidian vermicule and its application |
| 04/07/2004 | CN1144596C Chinese medicine prepn. with immunity strengthening effect |
| 04/07/2004 | CN1144595C Anticancer capsule and preparing mehtod thereof |
| 04/07/2004 | CN1144594C External-use plaster for softening dry feces and dissipating mass |
| 04/07/2004 | CN1144581C Health giving bathing mud |
| 04/06/2004 | US6716869 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716812 Calcitonin promotes fertilizing ability in mammalian sperm and is useful for treatment of conditions of low fertility in humans and animals |
| 04/06/2004 | US6716624 GSK3 polypeptides |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716435 Product comprising liquid absorbent structure and viable non-pathogenic lactic acid-producing spore-forming bacteria consisting essentially of bacillus coagulans present on external surface |
| 04/06/2004 | US6716434 Composition and method for immunostimulation in non- mammalian vertebrates |
| 04/06/2004 | US6716425 Administering to mammal cells modified by in vitro treatment with cytokine and gamma irradiation at dosage to irreversible arrest proliferation but not interfere with cytotoxicity |
| 04/06/2004 | US6716424 Streptococcus and isoflavone-containing composition |
| 04/06/2004 | US6716208 Implantable device and use therefor |
| 04/02/2004 | WO2004031372A1 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 04/02/2004 | CA2435274A1 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/01/2004 | WO2004027063A1 Use of sirnas for gene silencing in antigen presenting cells |
| 04/01/2004 | WO2004027052A1 Th1 cell adoptive immunotherapy |
| 04/01/2004 | WO2004027051A2 Use of a fusion polypeptide for obtaining pluripotent nonembryonic stem cells |
| 04/01/2004 | WO2004027033A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | WO2004026332A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | WO2004026244A2 Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
| 04/01/2004 | WO2004026238A2 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 04/01/2004 | WO2004026154A1 Insemination device |
| 04/01/2004 | WO2004015056A3 Immunomodulating compositions, processes for their production and uses therefor |
| 04/01/2004 | WO2004001032A3 Stable adenoviral vectors and methods for propagation thereof |
| 04/01/2004 | WO2003104443A3 Hair follicle mesenchymal stem cells and use thereof |
| 04/01/2004 | WO2003102162A3 Novel tolerogenic dendritic cells and therapeutic uses therefor |
| 04/01/2004 | WO2003097799A3 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS |
| 04/01/2004 | WO2003091398A3 Compositions and methods for stem cell delivery |
| 04/01/2004 | WO2003085123A3 Methods anc compositions for in vivo clearance of pathogens |
| 04/01/2004 | WO2003084343A3 Method and dietary composition for improving fat digestibility |
| 04/01/2004 | WO2003078588A3 Primitive and proximal hepatic stem cells |
| 04/01/2004 | WO2003077865A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003077864A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003072029A3 Methods of extending corneal graft survival |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003048336A3 Cultured cells from pancreatic islets |
| 04/01/2004 | WO2003024989A9 Activation and expansion of cells |
| 04/01/2004 | WO2003017913A8 Compositions, methods and apparatus for surgical procedures |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | US20040063206 Preparing lyophilized hydrogel of crosslinked alginate or hyaluronic acid for high throughput screening and tissue engineering |
| 04/01/2004 | US20040063204 Insulin-producing cell isolated from in vitro culture of bone marrow cells for reducing hyperglycemia in diabetic animal; antidiabetic agents |
| 04/01/2004 | US20040063202 Neurogenesis from hepatic stem cells |
| 04/01/2004 | US20040063189 Bacteriophages that infect bacillus bacteria (anthrax) |
| 04/01/2004 | US20040063173 Hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |